← Leaderboards
Anthony Arnold Amato
Brigham And Women'S Hospital
$6,781,613
Attributed
$8,438,502
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$8,438,502 · 4
By mechanism
U01$7,057,541 · 1
R01$1,374,639 · 1
M01$6,322 · 2
Top collaborators
- Nuria Carrillo2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Zara R Cooper$5,346,007
- Finnian R McCausland$3,327,661
- Arthur Joseph Barsky$7,699,340
- David A. Hafler$48,350,086
- Karen H Costenbader$16,932,994
Others in their field
Top investigators on “Muscle”
- Kenton M Sanders · University Of Nevada Reno$54,512,961
- Lynn A Sleeper · New England Research Institutes, Inc.$48,671,277
- Clifford B Saper · Harvard University (Medical School)$38,171,545
- Charles P Emerson · University Of Pennsylvania$37,572,397
- Jeffrey S Chamberlain · University Of Michigan At Ann Arbor$36,830,932
- Mary McGrae McDermott · Northwestern University$36,469,369
Research focus
MuscleDouble-Blind MethodMyopathySafetyFutureRandomizedTreatment EffectDesignPatient RecruitmentsMannosamineOutcome MeasureCaringPlacebosPatient PopulationNatural HistoryBaseOpen LabelAnabolismDouble-Blind Placebo Controlled TrialDisease ProgressionEnzymesAwarenessDisabilityMulticenter Studies
Grant awards (10)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects with GNE Myopathy$1,103,873
U01 · FY2023 · AR · contact PI
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects with GNE Myopathy$1,364,626
U01 · FY2022 · AR · contact PI
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects with GNE Myopathy$1,275,264
U01 · FY2021 · AR · contact PI
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects with GNE Myopathy$1,416,244
U01 · FY2020 · AR · contact PI
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects with GNE Myopathy$1,897,534
U01 · FY2017 · AR · contact PI
NONDYSTROPHIC MYOTONIAS: GENOTYPE-PHENOTYPE CORRELATION AND LONGITUDINAL STUDY$821
M01 · FY2008 · RR · contact PI
A Pilot Study of Etanercept in Dermatomyositis$471,578
R01 · FY2007 · NS · contact PI
NONDYSTROPHIC MYOTONIAS: GENOTYPE-PHENOTYPE CORRELATION AND LONGITUDINAL STUDY$5,501
M01 · FY2007 · RR · contact PI
A Pilot Study of Etanercept in Dermatomyositis$440,456
R01 · FY2006 · NS · contact PI
A Pilot Study of Etanercept in Dermatomyositis$462,605
R01 · FY2005 · NS